Sharp Versus Blunt Fascial Incision at Caesarean Section

October 18, 2011 updated by: Anna Aabakke, Holbaek Sygehus

Sharp Versus Blunt Fascial Incision at Caesarean Section: A Prospective Randomized Double-blinded Case-Control Study With the Case as it's Own Control.

The purpose of this study is to compare sharp and blunt fascial entry during caesarean section on the same patient. The study is performed on woman having cesarean section for the first time and who have not previously had lower abdominal surgery done. The following parameters are registered:

  1. The preferred side evaluated by the patient 3 months postoperatively.
  2. The patient evaluated difference in pain on the right vs. left side 1, 3 and 7 days and 1 and 3 months postoperatively.
  3. The rate and side of infection.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Holbaek, Denmark, 4300
        • Department of Gynaechology and Obstetrics, Holbaek Hospital
      • Hvidovre, Denmark, 2650
        • Department of Gynaecology and obstetrics, Hvidovre University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Woman having caesarean section for the first time
  • Woman, who have had no previous lower abdominal surgery
  • Woman who speak and understand Danish
  • Woman who can give informed consent

Exclusion Criteria:

  • Diabetes Mellitus (This does not include gestational diabetes)
  • Infection
  • Regular treatment with immunosuppressives
  • Alcohol or drug abuse
  • Age under 18 years old
  • Chronic pain disease eg. fibromyalgia, rheumatoid arthritis
  • BMI over 35

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Right sharp, left blunt
Blunt fascial entry on the left side of the midline and sharp fascial entry on the right side of the midline.
Blunt fascial entry on the left side of the midline and sharp fascial entry on the right side of the midline.
EXPERIMENTAL: Right blunt, left sharp
Blunt fascial entry on the right side of the midline and sharp fascial entry on the left side of the midline.
Blunt fascial entry on the right side of the midline and sharp fascial entry on the left side of the midline.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preferred side of the scar evaluated by the patient 3 months postoperatively
Time Frame: 3 months
The overall preference of scar side - left, right or no difference - taking the entire postoperative 3 months into account as evaluated by the patient.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The difference in pain between the two sides of the scar
Time Frame: 1, 3 and 7 days postoperatively
Difference in painscore between the two ends of the scar on the 1st, 2nd and 7th postoperative day. Pain is registered by a score on a vas-scale from 0-10.
1, 3 and 7 days postoperatively
The difference in pain between the two sides of the scar
Time Frame: 1 and 3 months postoperatively
Description: Difference in painscore between the two ends of the scar one and three months postoperatively. Pain is registered by a score on a vas-scale from 0-10.
1 and 3 months postoperatively
Pain on the two sides of the scar
Time Frame: 1, 3 and 7 days postoperatively
Pain in the two ends of the scar registered by a score on a vas-scale from 0-10 1, 3 and 7 days postoperatively.
1, 3 and 7 days postoperatively
Pain in the two sides of the scar
Time Frame: 1 and 3 months postoperatively
Pain in the two sides of the scar is registered by a score on a vas-scale from 0-10 1 and 3 months postoperatively.
1 and 3 months postoperatively
Infection
Time Frame: 7 days
The rate of postoperative infection and what side of the scar - right or left -that is infected.
7 days
Infection
Time Frame: 1 and 3 months postoperatively
The rate of postoperative infection and what side of the scar - right or left -that is infected.
1 and 3 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Niels Jørgen Secher, Professor, M.D., Dep. Gynaecology and Obstetrics, Hvidovre University Hospital
  • Principal Investigator: Anna Aabakke, M.D., Dep. Gynaecology and Obstetrics, Holbaek Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (ACTUAL)

July 1, 2011

Study Completion (ACTUAL)

October 1, 2011

Study Registration Dates

First Submitted

February 16, 2011

First Submitted That Met QC Criteria

February 16, 2011

First Posted (ESTIMATE)

February 17, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

October 19, 2011

Last Update Submitted That Met QC Criteria

October 18, 2011

Last Verified

October 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • Fascia Study
  • H-2-2010129 (OTHER: The Danish National Committee on Biomedical Research Ethics)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section

Clinical Trials on Blunt left, sharp right

Subscribe